ConductScience.org, home

Gene · 990

NIH grants1,788

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCDC6 papersNewest fiscal year
R01ES016486Regulation of the DNA Damage Response22025
R01GM024663Genetic Analysis of Nematode Egg Laying and Co-regulated Behavioral Systems22025
R35GM142695Statistical and Machine Learning Methods to Address Biomedical Challenges for Integrating Multi-view Data22025
R37GM071747Mechanistic Studies of Replication Initiation in Prokaryotes22025
T32CA009109Cancer Research Training Program: From Molecular Mechanisms to Therapeutic Strategies22025
T32CA009138Molecular, Genetic and Cellular Targets of Cancer Training Program22025
T32CA009302Leveraging innovative technologies in basic and clinical cancer research22025
T32CA070085Training Program in Signal Transduction and Cancer22025
T32CA148724Cancer Biology Training Program22025
T32GM135128NRSA in Genetics22025
U01DA045300The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model22025
ZIAAG000394Post-transcriptional regulation of energy usage: glucose and lipid metabolism22025
ZIABC006150DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs22025
ZIABC010499Maryland Prostate Cancer Case-Control Study22025
ZIALM000061Finding Protein Sequence Motifs--Methods And Applications22025
ZIALM594244Evolutionary Analysis and Comparative Genomics of Protein Superfamilies22025
ZIBHG000196Inter- and Intra-Species Comparative Sequencing22025
ZICBC011430CPTR - Mass Spectrometry Unit22025
ZICES102445Gene Expression and Microarrays22025
F30OD031914MicroRNA-375 regulation of enteroendocrine cell biology in diet-induced obesity and bariatric surgery12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/990/grants?page=4